Rankings
▼
Calendar
IMNM FY 2020 Earnings — Immunome, Inc. Revenue & Financial Results | Market Cap Arena
IMNM
Immunome, Inc.
$2B
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$755,000
Operating Income
-$12M
Net Income
-$18M
EPS (Diluted)
$-1.69
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$13M
Stock-Based Comp.
$621,000
Balance Sheet
Total Assets
$45M
Total Liabilities
$3M
Stockholders' Equity
$41M
Cash & Equivalents
$40M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$755,000
-$615,000
-22.8%
Operating Income
-$12M
-$10M
-18.5%
Net Income
-$18M
-$11M
-69.1%
← Q4 2019
All Quarters
Q1 2020 →